Boston Scientific Corporation vs Eli Lilly And Co — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Eli Lilly And Co trades at $1,213.06 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 15.4× Boston Scientific Corporation's market cap, and Eli Lilly And Co pays a 0.56% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | LLY | |
|---|---|---|
Market Cap | $71.46B | $1.10T |
Sector | Health | Health |
52-Week High | $108.14 | $1.24K |
52-Week Low | $42.63 | $639.43 |
Enterprise Value | $83.55B | $1.14T |
Dividend Yield | — | 0.56% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →